Technology
Neutral
Revolution Medicines outlines multiple Phase III trial launches and commercial buildout amid increased R&D investment
Breaking news from global financial markets
2 days ago
Read More
2 days ago
2,114
2 days ago
1,230
2 days ago
706
2 days ago
695
2 days ago
3,587
2 days ago
3,551
2 days ago
4,863
2 days ago
1,311
2 days ago
4,046
2 days ago
941
Relative Strength Alert For Adient
Technology
2 days ago
1,323
2 days ago
2,055
2 days ago
3,044
QXO Becomes Oversold
Technology
2 days ago
589
2 days ago
4,908
2 days ago
607
3 days ago
4,785
3 days ago
2,204
Trending Now
1
17 out of 18 Information Technology stocks deliver EPS wins this week: Earnings...
35,088
23 minutes ago
2
Half of Holiday Shoppers Are More Likely to Complete Their Purchase With Buy Now...
43,952
38 minutes ago
3
Elon Musk Says Optimus Robot Will Replace Jobs and Enable Universal Income
7,775
52 minutes ago
4
Energy company serving 38 states files Chapter 11 bankruptcy
8,440
52 minutes ago
5
Cheers! Beer and Liquor Stocks on Sale With High Yields to 7.25%
30,827
55 minutes ago